Literature DB >> 30581235

How to Manage Thrombocytopenia with ECLS: A Proposal of Clinical Reasoning Tools.

Adrien Koeltz1,2, Nicolas Gendron2,3,4, Nadine Ajzenberg2,3,4, Dan Longrois1,2,4.   

Abstract

Extracorporeal life support (ECLS) is increasingly used as a rescue therapy in patients with refractory cardiac/respiratory failure for temporary support or bridge to decision-making in both adult and pediatric patients. Complications such as bleeding and thrombosis remain major causes of morbidity and mortality in patients treated with ECLS. Hemostatic complications related to ECLS are multifactorial in patients with multiple organ dysfunctions and are incompletely characterized. Persisting thrombocytopenia and/or platelet dysfunction is the most frequent one. Herein, we report the case of a patient who developed severe thrombocytopenia after 5 days of ECLS associated with thrombi deposition in the circuit and oxygenator. After ECLS circuit and membrane change, we observed an increase and normalization in platelet count in 3 days. We propose a case-based reasoning to manage thrombocytopenia with ECLS.

Entities:  

Keywords:  extracorporeal life support; hemocompatibility; thrombocytopenia; thrombosis

Mesh:

Substances:

Year:  2018        PMID: 30581235      PMCID: PMC6296451     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  9 in total

1.  Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.

Authors:  Palak Shah; Vivek M Mehta; Jennifer A Cowger; Keith D Aaronson; Francis D Pagani
Journal:  J Heart Lung Transplant       Date:  2013-08-19       Impact factor: 10.247

Review 2.  A meta-analysis of complications and mortality of extracorporeal membrane oxygenation.

Authors:  Alberto Zangrillo; Giovanni Landoni; Giuseppe Biondi-Zoccai; Massimiliano Greco; Teresa Greco; Giacomo Frati; Nicolò Patroniti; Massimo Antonelli; Antonio Pesenti; Federico Pappalardo
Journal:  Crit Care Resusc       Date:  2013-09       Impact factor: 2.159

Review 3.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Authors:  Russell P Rother; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

4.  Hemostatic complications of cardiopulmonary bypass.

Authors:  R W Colman
Journal:  Am J Hematol       Date:  1995-04       Impact factor: 10.047

Review 5.  Extracorporeal membrane oxygenation-hemostatic complications.

Authors:  Deirdre A Murphy; Lisen E Hockings; Robert K Andrews; Cecile Aubron; Elizabeth E Gardiner; Vincent A Pellegrino; Amanda K Davis
Journal:  Transfus Med Rev       Date:  2014-12-18

Review 6.  Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.

Authors:  S Susen; A Rauch; E Van Belle; A Vincentelli; P J Lenting
Journal:  J Thromb Haemost       Date:  2015-09-25       Impact factor: 5.824

7.  Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity.

Authors:  Karla Lehle; Alois Philipp; Otto Gleich; Andreas Holzamer; Thomas Müller; Thomas Bein; Christof Schmid
Journal:  ASAIO J       Date:  2008 Nov-Dec       Impact factor: 2.872

8.  Complications of extracorporeal life support systems using heparin-bound surfaces. The risk of intracardiac clot formation.

Authors:  D D Muehrcke; P M McCarthy; R W Stewart; S Seshagiri; D A Ogella; R C Foster; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  1995-09       Impact factor: 5.209

9.  Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study.

Authors:  Cecile Aubron; Allen C Cheng; David Pilcher; Tim Leong; Geoff Magrin; D Jamie Cooper; Carlos Scheinkestel; Vince Pellegrino
Journal:  Crit Care       Date:  2013-04-18       Impact factor: 9.097

  9 in total
  2 in total

1.  Determinants of Arterial Pressure of Oxygen and Carbon Dioxide in Patients Supported by Veno-Arterial ECMO.

Authors:  Stefan Andrei; Maxime Nguyen; Vivien Berthoud; Bastian Durand; Valerian Duclos; Marie-Catherine Morgant; Olivier Bouchot; Belaid Bouhemad; Pierre-Grégoire Guinot
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964

2.  Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China.

Authors:  Jing-Chun Song; Shu-Yuan Liu; Feng Zhu; Ai-Qing Wen; Lin-Hao Ma; Wei-Qin Li; Jun Wu
Journal:  Mil Med Res       Date:  2020-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.